American Medical Systems and other subsidiaries of Endo Pharmaceuticals, Inc. were removed earlier this month as defendants in the federal consolidations of transvaginal mesh lawsuits (MDL-2325, U.S. District Court for the Southern District of West Virginia), according to court documents reviewed by the Rottenstein Law Group, a transvaginal mesh law firm.

A court order* from Chief Judge Joseph R. Goodwin said that “the court will dismiss in all pending cases (whether filed directly or transferred), all claims pending against the Endo entities without prejudice.”

“The removal of those defendants from the multidistrict litigation does not mean that American Medical Systems cannot be sued for the serious alleged side effects of its transvaginal mesh products,” said Rochelle Rottenstein, principal of the Rottenstein Law Group. “What it means is that they won’t be included in the existing MDLs, which is a pretrial consolidation of common causes and acts of discovery.”

Read full story at PRWeb.com: Transvaginal Mesh Lawsuit Update: Rottenstein Law Group Responds to Court Order to Remove American Medical Systems as Mesh Defendant